Photomedex (PHMD) Misses Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Canaccord Genuity Downgrades PhotoMedex (PHMD) to Hold
August 8, 2014 7:18 AM EDTCanaccord Genuity downgraded PhotoMedex (NASDAQ: PHMD) from Buy to Hold with a price target of $8.00 (from $15.00).
For an analyst ratings summary and ratings history on PhotoMedex click here. For more ratings news on PhotoMedex click here.
Shares of PhotoMedex closed at $9.31 yesterday.
... More